521
Views
9
CrossRef citations to date
0
Altmetric
Review

Safety of recombinant coagulation factors in treating hemophilia

&
Pages 75-85 | Received 14 Oct 2018, Accepted 22 Jan 2019, Published online: 22 Feb 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Emanuela Marchesini, Massimo Morfini & Leonard Valentino. (2021) Recent Advances in the Treatment of Hemophilia: A Review. Biologics: Targets and Therapy 15, pages 221-235.
Read now
Massimo Franchini, Giuseppe Marano, Ilaria Pati, Eva Veropalumbo, Stefania Vaglio, Simonetta Pupella, Francesca Masiello, Mario Cruciani, Carlo Mengoli & Giancarlo Maria Liumbruno. (2020) Investigational drugs to treat hemophilia. Expert Opinion on Investigational Drugs 29:3, pages 295-301.
Read now

Articles from other publishers (7)

Minerva Codruta Badescu, Oana Viola Badulescu, Lăcrămioara Ionela Butnariu, Iris Bararu Bojan, Maria Cristina Vladeanu, Nicoleta Dima, Cristiana Elena Vlad, Liliana Georgeta Foia, Manuela Ciocoiu & Ciprian Rezus. (2022) Cardiovascular Risk Factors in Patients with Congenital Hemophilia: A Focus on Hypertension. Diagnostics 12:12, pages 2937.
Crossref
Jianhua Mao, Yun Wang, Wei Zhang, Yan Shen, Guowei Zhang, Wenda Xi, Qiang Wang, Zheng Ruan, Jin Wang & Xiaodong Xi. (2022) Long-term correction of hemorrhagic diathesis in hemophilia A mice by an AAV-delivered hybrid FVIII composed of the human heavy chain and the rat light chain. Frontiers of Medicine 16:4, pages 584-595.
Crossref
Irving Jair Lara-Navarro & Ana Rebeca Jaloma-Cruz. (2022) Current Therapies in Hemophilia: From Plasma-Derived Factor Modalities to CRISPR/Cas Alternatives. The Tohoku Journal of Experimental Medicine 256:3, pages 197-207.
Crossref
Steven W. Pipe, Rebecca Kruse‐Jarres, Johnny N. Mahlangu, Glenn F. Pierce, Flora Peyvandi, Peter Kuebler, Christian De Ford, Fabián Sanabria, Richard H. Ko, Tiffany Chang & Charles R.M. Hay. (2021) Establishment of a framework for assessing mortality in persons with congenital hemophilia A and its application to an adverse event reporting database. Journal of Thrombosis and Haemostasis 19, pages 21-31.
Crossref
Alexander A. Hysong, Samuel L. Posey, Deke M. Blum, Michael A. Benvenuti, Teresa A. Benvenuti, Samuel R. Johnson, Thomas J. An, Jessica K. Devin, William T. Obremskey, Jeffrey E. Martus, Stephanie N. Moore-Lotridge & Jonathan G. Schoenecker. (2020) Necrotizing Fasciitis: Pillaging the Acute Phase Response. Journal of Bone and Joint Surgery 102:6, pages 526-537.
Crossref
Charles Nakar & Amy Shapiro. (2019) Hemophilia A with inhibitor: Immune tolerance induction (ITI) in the mirror of time. Transfusion and Apheresis Science 58:5, pages 578-589.
Crossref
Antonio Liras & Luis Romeu. (2019) Dental management of patients with haemophilia in the era of recombinant treatments: increased efficacy and decreased clinical risk. BMJ Case Reports 12:4, pages e227974.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.